Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30058638HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS30020716HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS30058639HIVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS20036587HPVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TVIS20023553HPVENSG00000169313.10protein_codingP2RY12NoNo64805Q9H244
TCGA Plot Options
Drug Information
GeneP2RY12
DrugBank IDDB00374
Drug NameTreprostinil
Target IDBE0000110
UniProt IDQ9H244
Regulation Typeagonist
PubMed IDs30485728
CitationsBacha NC, Levy M, Guerin CL, Le Bonniec B, Harroche A, Szezepanski I, Renard JM, Gaussem P, Israel-Biet D, Boulanger CM, Smadja DM: Treprostinil treatment decreases circulating platelet microvesicles and their procoagulant activity in pediatric pulmonary hypertension. Pediatr Pulmonol. 2019 Jan;54(1):66-72. doi: 10.1002/ppul.24190. Epub 2018 Nov 28.
GroupsApproved; Investigational
Direct ClassificationPhenoxyacetic acid derivatives
SMILES[H][C@]12C[C@@H](O)[C@H](CC[C@@H](O)CCCCC)[C@@]1([H])CC1=C(C2)C(OCC(O)=O)=CC=C1
Pathways
PharmGKBPA164768801
ChEMBLCHEMBL1237119